D.E. Shaw & Co’s CRH Medical Corporation CRHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-54,900
| Closed | -$217K | – | 5185 |
|
|
2021
Q1 | $217K | Sell |
54,900
-64,800
| -54% | -$210K | ﹤0.01% | 3821 |
|
|
2020
Q4 | $280K | Buy |
119,700
+26,000
| +28% | +$63.7K | ﹤0.01% | 3626 |
|
|
2020
Q3 | $202K | Sell |
93,700
-41,000
| -30% | -$95.6K | ﹤0.01% | 3597 |
|
|
2020
Q2 | $281K | Sell |
134,700
-57,700
| -30% | -$117K | ﹤0.01% | 3654 |
|
|
2020
Q1 | $257K | Sell |
192,400
-56,000
| -23% | -$183K | ﹤0.01% | 3546 |
|
|
2019
Q4 | $861K | Sell |
248,400
-5,600
| -2% | -$17.7K | ﹤0.01% | 3086 |
|
|
2019
Q3 | $780K | Buy |
254,000
+60,700
| +31% | +$180K | ﹤0.01% | 2966 |
|
|
2019
Q2 | $582K | Sell |
193,300
-131,300
| -40% | -$376K | ﹤0.01% | 2999 |
|
|
2019
Q1 | $858K | Buy |
324,600
+400
| +0.1% | +$1.24K | ﹤0.01% | 2695 |
|
|
2018
Q4 | $994K | Sell |
324,200
-61,800
| -16% | -$204K | ﹤0.01% | 2662 |
|
|
2018
Q3 | $1.54M | Buy |
386,000
+82,100
| +27% | +$303K | ﹤0.01% | 2382 |
|
|
2018
Q2 | $950K | Buy |
303,900
+144,500
| +91% | +$461K | ﹤0.01% | 2730 |
|
|
2018
Q1 | $403K | Buy |
159,400
+70,400
| +79% | +$197K | ﹤0.01% | 2989 |
|
|
2017
Q4 | $234K | Buy |
89,000
+77,700
| +688% | +$173K | ﹤0.01% | 3361 |
|
|
2017
Q3 | $29K | Sell |
11,300
-88,600
| -89% | -$272K | ﹤0.01% | 3419 |
|
|
2017
Q2 | $569K | Buy |
99,900
+57,800
| +137% | +$375K | ﹤0.01% | 2748 |
|
|
2017
Q1 | $344K | Buy |
+42,100
| New | +$291K | ﹤0.01% | 2908 |
|
D.E. Shaw & Co's CRHM Position: Q2 2021 in Review
D.E. Shaw & Co sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 54,900 shares — an estimated $217K sold.
D.E. Shaw & Co first reported a position in CRHM in Q1 2017 and held it in 17 quarters. The position peaked at $1.54M in Q3 2018. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.
- D.E. Shaw & Co reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
- D.E. Shaw & Co sold 54,900 CRH Medical Corporation shares in Q2 2021, an estimated $217K.
- D.E. Shaw & Co first reported a position in CRH Medical Corporation in Q1 2017 and held it in 17 quarters.
- D.E. Shaw & Co's CRH Medical Corporation position peaked at $1.54M in Q3 2018.
- 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.
Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.